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Nopporn Apiwattanakul5,6, Walid Awad5, Kelly L. Miners2, Stephen J. Lalor7, Julie C. Ribot8, Song Baik9, Barry Moran1, Aoife McGinley1,
Valerie Pivorunas10, Lori Dowding10, Michael Macoritto10, Jesus Paez-Cortez10, Anthony Slavin10, Graham Anderson9, Bruno Silva-Santos8,
Karsten Hokamp4, David A. Price2, Paul G. Thomas5, Rachel M. McLoughlin7, and Kingston H.G. Mills1
T cells are classically recognized as distinct subsets that express αβ or γδ TCRs. We identify a novel population of T cells that
coexpress αβ and γδ TCRs in mice and humans. These hybrid αβ-γδ T cells arose in the murine fetal thymus by day 16 of
ontogeny, underwent αβ TCR–mediated positive selection into CD4+ or CD8+ thymocytes, and constituted up to 10% of
TCRδ+ cells in lymphoid organs. They expressed high levels of IL-1R1 and IL-23R and secreted IFN-γ, IL-17, and GM-CSF in
response to canonically restricted peptide antigens or stimulation with IL-1β and IL-23. Hybrid αβ-γδ T cells were
transcriptomically distinct from conventional γδ T cells and displayed a hyperinflammatory phenotype enriched for
chemokine receptors and homing molecules that facilitate migration to sites of inflammation. These proinflammatory T cells
promoted bacterial clearance after infection with Staphylococcus aureus and, by licensing encephalitogenic Th17 cells, played a
key role in the development of autoimmune disease in the central nervous system.
Introduction
MHC-restricted CD4+ and CD8+ T cells typically mediate
pathogen-specific adaptive immunity and express αβ TCRs. In
contrast, γδ T cells play an important role in innate immunity at
mucosal surfaces but can also display features of immunological
memory, analogous to conventional αβ T cells (Misiak et al.,
2017; Sutton et al., 2009). The accepted dogma is that common
lymphoid progenitors develop into cells that express either αβ or
γδ TCRs and that each population subsequently occupies a spe-
cific and highly conserved niche within the immune system.
γδ T cells are required for optimal innate and adaptive im-
mune responses to infection and tumors (Murphy et al., 2014;
Rei et al., 2014; Silva-Santos et al., 2015). They are the first
lymphocytes to emerge in the fetus, and before full maturation
of the immune system, they mediate protective functions in
young animals (Shibata et al., 2007; Sinkora et al., 2005). A
unique feature of murine γδ T cells is the preferential expres-
sion of different TCRγ variable region (Vγ) segments in different
tissues. For example, Vγ5+ γδ T cells are present in skin, Vγ6+ γδ
T cells localize to the reproductive mucosa, and Vγ1+ or Vγ4+ γδ
T cells are found in secondary lymphoid organs (nomenclature
of Heilig and Tonegawa, 1986). γδ T cells produce an array of
cytokines, including IFN-γ, IL-4, IL-17A, IL-17F, IL-21, IL-22, GM-
CSF, and TNF-α (Lockhart et al., 2006; Ribot et al., 2009; Sutton
et al., 2012).
Although γδ T cells display characteristics of adaptive
memory, they can also produce IL-17 upon stimulation with
IL-1β and IL-23 in the absence of TCR engagement and provide
an early source of innate proinflammatory cytokines that help
amplify T helper type 17 (Th17) responses in certain autoimmune
and infectious diseases (Conti et al., 2014; Crowley et al., 1997;
Sutton et al., 2009). In humans with multiple sclerosis, in-
creased frequencies of γδ T cells have been detected in acute
brain lesions (Hvas et al., 1993; Wucherpfennig et al., 1992), and
clonal expansions of γδ T cells have been observed in cerebro-
spinal fluid during the early stages of disease (Shimonkevitz
et al., 1993). Similarly, IL-17–producing Vγ4+ T cells infiltrate
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the brain and spinal cord of mice with experimental autoim-
mune encephalomyelitis (EAE; Price et al., 2012; Sutton et al.,
2009). Vγ4+ T cells also mediate inflammation via IL-17 pro-
duction in the dermis of mice with psoriasis (Cai et al., 2011) and
accumulate in the draining LNs and joints of mice with collagen-
induced arthritis (Roark et al., 2007).
In this study, we identified a discrete population of T cells
that coexpressed αβ and γδ TCRs. These hybrid αβ-γδ T cells
were transcriptomically distinct from conventional γδ T cells,
poised to migrate to sites of inflammation, and responsive to
MHC class I (MHCI)–restricted or MHCII-restricted peptide
antigens or stimulation with IL-1β and IL-23. In line with these
findings, hybrid αβ-γδ T cells protected against infection with
Staphylococcus aureus and, by licensing encephalitogenic Th17
cells, triggered autoimmune pathology in the central nervous
system (CNS).
Results and discussion
Identification of hybrid αβ-γδ T cells
Initial flow cytometric analyses with antibodies specific for the
constant regions of TCRδ and TCRβ unexpectedly revealed a rare
population of TCRδ+TCRβ+ cells in the LNs of WT C57BL/6 mice
(Fig. 1 A and Fig. S1 A). These findings were substantiated using
confocal microscopy, which demonstrated surface expression of
TCRβ on purified TCRδ+ cells (Fig. S1 B), and RT-PCR, which
demonstrated the presence of transcripts encoding the joining
region of TCRβ (Trbj) in purified TCRδ+ cells (Fig. S1 C). More-
over, TCRδ+ cells coexpressed TCRβ and various TCRα variable
region (Vα) segments (Fig. 1 B), and some Vγ4+, Vγ1+, and
Vγ4–Vγ1− T cells coexpressed TCRδ and TCRβ (Fig. 1 C and Fig.
S1, D and E). ImageStream experiments confirmed coexpression
of Vγ4 with TCRδ and TCRβ at the single-cell level (Fig. 1 D). In
addition, flow cytometric analyses revealed that ∼6% of
Vγ4+TCRδ+ cells expressed TCRβ (Fig. S1 F). These hybrid αβ-γδ
T cells expressed higher levels of CD3ε than TCRδ+TCRβ− cells
(Fig. 1 E), together with either CD4 or CD8α (Fig. 1 F). Coex-
pression of αβ and γδ TCRs was further validated using TCRα−/−
and TCRβ−/−mice, which lacked hybrid αβ-γδ T cell populations,
whereas ∼7% of Vγ4+TCRδ+ cells in WT mice expressed TCRβ
(Fig. 1 G). Importantly, Vγ4+TCRδ+TCRβ+ cells were present in
MHCI−/− and MHCII−/− mice (Fig. 1 G). CD4+Vγ4+TCRδ+TCRβ+
cells were absent in MHCII−/− mice, whereas CD8+Vγ4+TCRδ+
TCRβ+ cells were absent in MHCI−/− mice (Fig. S1 G). Double-
negative cells were the most predominant population in each
strain (Fig. S1 G). An examination of the ontogeny of hybrid
αβ-γδ T cells revealed that Vγ4+ cells emerged in the thymus
between embryonic days (E) 14 and 16 (E14 and E16; Fig. 1 H).
Although the majority of these Vγ4+ cells were TCRδ+TCRβ−
(conventional γδ cells), we detected a clear population of Vγ4+
cells that coexpressed TCRβ. These findings suggest that hybrid
αβ-γδ T cells develop in the embryonic thymus in synchrony
with the early waves of conventional γδ T cells, following the
same CD4 and CD8 expression patterns as γδ (double negative)
or αβ T cells (MHC restricted).
Flow cytometric analyses of human peripheral blood mono-
nuclear cells (PBMCs) revealed a rare population of cells (<1% of
CD3+ T cells) that coexpressed TCRαβ and Vδ2 (Fig. 1 I) and
further showed that ∼10% of all circulating Vδ2+ cells expressed
TCRαβ (Fig. 1 J). These data provide preliminary evidence that
hybrid αβ-γδ T cells are also present in humans.
Molecular analysis of TCR expression in Vγ4+TCRβ+ cells
To examine the molecular basis of αβ and γδ TCR coexpression,
we used an unbiased approach (Quigley et al., 2011) to amplify all
expressed Tra, Trb, Trg, and Trd gene rearrangements in flow-
purified Vγ4+TCRβ+ cells. Analysis of the Tra and Trb gene ex-
pression profiles revealed substantial heterogeneity (Fig. 2 A).
We also detected Trgv2 gene transcripts, presumably reflecting
antibody cross-recognition of Vγ2 and Vγ4. The associated Trd
gene transcripts were heavily biased toward Trdv2-2 and Trdv5.
Of note, disruption of a single chromatin loop facilitates “de-
fault” rearrangements with Trdv2-2 (Chen et al., 2015), which
also occur in ∼42% of thymocytes in WT mice, and Trdv5 is lo-
cated in a reversed transcriptional orientation 39 of the Trdc gene
(Glusman et al., 2001).
To confirm these findings, we flow-sorted single Vγ4+
TCRδ+TCRβ+ cells from the LN cells of mice with EAE (Fig. 2 B).
Functional Tra, Trb, Trg, and Trd gene rearrangements, consis-
tent with the index sort parameters, were detected in∼9% (7/79)
of these cells (Fig. 2 C). In line with the population-level data,
Trgv2 rearranged exclusively with Trgj2, Trgv4 rearranged ex-
clusively with Trgj1, and Trdv2-2 and Trdv5 rearranged exclu-
sively with Trdj1. Moreover, the CDR3γ and CDR3δ loop
sequences were highly conserved, irrespective of gene use, and
matched those identified in a recent study of CCR6+CD27− γδ
T cells (Kashani et al., 2015). No clear patterns were observed
among Tra and Trb gene transcripts amplified from single
Vγ4+TCRδ+TCRβ+ cells. These data show that hybrid αβ-γδ
T cells coexpress diverse TCRα and TCRβ chains and a limited
array of TCRγ and TCRδ chains.
Hybrid αβ-γδ T cells can be activated innately or via αβ or
γδ TCRs
We then addressed the functionality of hybrid αβ-γδ T cells after
stimulation with IL-1β and IL-23, which are known to promote
the activation of innate γδ T cells (Sutton et al., 2009), or ligation
of the expressed αβ or γδ TCRs. Vγ4+ T cells produced IFN-γ and
IL-17 in response to IL-1β and IL-23 (Fig. 3 A). Moreover, de-
pletion of Vγ4+ cells from the CD3+ T cell pool abrogated IFN-γ
and IL-17 production elicited by IL-1β and IL-23 (Fig. 3 A), and
Vγ4+ hybrid αβ-γδ T cells more frequently expressed IL-1R1 or
IL-23R (Fig. 3 B) or coexpressed IL-1R1 and IL-23 (Fig. S2 A)
compared with conventional Vγ4+ γδ or αβ T cells. Stimulation
of hybrid αβ-γδ T cells with IL-1β and IL-23 induced the ex-
pression of Ifng and Il17a (Fig. 3 C), as well as the production of
IFN-γ and IL-17 (Fig. S2 B). Although Ifng and Il17a expression
was detected in the absence of TCR signaling, coactivation with
anti-CD3 enhanced IFN-γ expression at the gene and protein
levels. Hybrid αβ-γδ T cells also expressed Rorc, which encodes
RORγt, the transcription factor associated with IL-17 production
(Ivanov et al., 2006), and Sox13,which encodes the transcription
factor associated with IL-17–producing Vγ4+ γδ T cells (Gray
et al., 2013), after stimulation with IL-1β and IL-23 (Fig. S2 C).
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Next, we examined the ability of hybrid αβ-γδ T cells to re-
spond to MHCII-restricted antigens, initially using OT-II trans-
genic mice, which exclusively express αβ TCRs that recognize an
OVA peptide restricted by I-Ab. Purified TCRδ+ cells from OT-II
mice, but not WT mice, produced IFN-γ in response to dendritic
cells (DCs) pulsed with OVA, but not with KLH (Fig. S2 D).
Moreover, purified TCRδ+TCRβ+ cells, but not TCRδ+TCRβ− cells,
from OT-II mice produced IFN-γ, IL-17, and GM-CSF (Fig. 3 D)
and significantly up-regulated Tbx21, Rorc, Stat3, and Mcam in
response to OVA (Fig. S2 E). Co-stimulation of TCRδ+TCRβ+ cells
from OT-II mice with IL-1β and IL-23 in the presence of OVA-
pulsed DCs enhanced the production of IFN-γ and GM-CSF,
which was reversed by the addition of anti-MHCII (Fig. 3 E).
OVA stimulation reduced the production of IL-17 induced by IL-
1β and IL-23 (Fig. 3 E), potentially reflecting enhanced expres-
sion of Tbx21, which encodes T-bet, a transcription factor that
blocks Runx1-mediated transactivation of the Rorc promoter and
subsequent expression of IL-17. Stimulation of OT-II–derived γδ
T cells with OVA under Th1 and Th2 polarizing conditions also
enhanced the production of IFN-γ and IL-4 (Fig. S2 F). Further
evidence of MHCII-restricted peptide recognition by hybrid
αβ-γδ T cells was obtained using Vγ4+TCRβ+ cells purified from
WT mice immunized with myelin oligodendrocyte protein
(MOG) and CFA. IL-1β and IL-23 induced the expression of Tbx21
and Rorc (Fig. 3 F), as well as the production of IFN-γ, IL-17, and
GM-CSF, which was substantially enhanced in the presence of
MOG and DCs (Fig. 3, F and G; and Fig. S2 G).
The antigen specificity of hybrid αβ-γδ T cells was confirmed
using the correspondingMOG tetramer to stain LN cells 7 d after
the induction of EAE. Approximately 33% of Vγ4+TCRβ+ cells
stained with the MOG tetramer, in contrast to ∼12% of con-
ventional αβ T cells (Fig. S2 H). Moreover, we found that puri-
fied γδ T cells from OT-1 mice, which harbor transgenic CD8+
T cells specific for OVA257–264 presented by H-2Kb, produced
IFN-γ in the presence of OVA-pulsed DCs and IL-12 (Fig. S2 I).
These data suggest that hybrid αβ-γδ T cells respond in an
innate-like manner to IL-1β and IL-23, akin to conventional γδ
T cells, but also recognize peptide antigens presented by MHCII
or MHCI, akin to conventional αβ T cells.
The lack of well-defined antigens recognized by γδ T cells
precluded analysis of activation via γδ TCRs. Nonetheless, we
examined the expression of the natural killer group 2D (NKG2D)
receptor, which is crucial for innate-like lymphocyte recogni-
tion of stressed or infected cells (Correia et al., 2013). Hybrid
Vγ4+ αβ-γδ T cells expressed higher levels of NKG2D than
conventional Vγ4+ γδ or αβ T cells (Fig. S2 J). Expression of Ki67,
a marker of proliferation, was also significantly enhanced in
hybrid Vγ4+ αβ-γδ T cells, but not in conventional Vγ4+ γδ
T cells, after co-culture with YAC-1 cells, which constitutively
express NKG2D ligands (Fig. S2 K). Moreover, stimulation of
TCRδ+TCRβ+ cells with an activating anti-TCRδ antibody sig-
nificantly increased the expression of Ifng, Il17a, Csf2, Mcam,
Tbx21, Rorc, and Il1r1 (Fig. S2 L), as well as the production of IL-17
driven by IL-1β and IL-23 (Fig. S2 M).
Further phenotypic analyses revealed that hybrid αβ-γδ
T cells displayed unique properties and certain features associ-
ated with conventional γδ T cells. The majority of hybrid αβ-γδ
T cells expressed CD27 (Fig. S3 A), whereas Vγ4+ γδ T cells were
either CD27+ or CD27−, demarcating the production of IFN-γ or
IL-17, respectively (Ribot et al., 2009). Moreover, CCR6, a che-
mokine receptor expressed on IL-17–secreting γδ T cells (Haas
et al., 2009; Papotto et al., 2017) and pathogenic Th17 cells during
EAE (Reboldi et al., 2009), was expressed by hybrid αβ-γδ and
conventional Vγ4+ γδ T cells, but not by αβ T cells (Fig. S3 A).
Similarly, CCR2, which allows Th17 cells to cross the blood–brain
barrier and is associated with the development of EAE (Kara
et al., 2015), was more commonly expressed by hybrid αβ-γδ
T cells relative to conventional γδ or αβ T cells. The integrin
CD49d, a subunit of the cell adhesion molecule α4β1, very late
antigen-4 (VLA-4), which is involved in the migration of en-
cephalitogenic T cells into the CNS (Yednock et al., 1992), was
expressed by ∼40% of hybrid αβ-γδ T cells but also by ∼20% of
conventional Vγ4+ γδ T cells (Fig. S3 A). In addition, hybrid
αβ-γδ T cells expressed IL-2R, CD25, and CD122 at higher fre-
quencies than conventional Vγ4+ γδ T cells or αβ T cells (Fig. S3
A). These observations indicate that hybrid αβ-γδ T cells share
some phenotypic features with γδ T cells but also exhibit char-
acteristics typically associated with cell activation andmigration.
Hybrid αβ-γδ T cells protect against S. aureus infection
To probe the biological relevance of these findings, we examined
the ability of hybrid αβ-γδ T cells to protect against infection
with S. aureus in a murine model, where a key role has been
defined for IL-17–producing γδ T cells (Murphy et al., 2014).
Mice infected with S. aureus displayed significantly elevated
concentrations of IL-17 and IL-1β in the peritoneal fluid 3 h after
infection (Fig. 3 H). At the same time point, there was a non-
significant increase in the absolute number of TCRδ+ cells
(Fig. 3 I) and a significant increase in the absolute number of
Vγ4+TCRβ+ cells in the peritoneal cavity (Fig. 3 J). In addition,
there was a significant increase in IFN-γ–producing and a
nonsignificant increase in IL-17–producing Vγ4+TCRδ+TCRβ+ cells
Figure 1. Identification of unconventional T cells that coexpress αβ and γδ TCRs. (A and B) Flow cytometric analysis of LN cells from WT mice, stained
for TCRδ and TCRβ, gated on live CD3+ T cells (A), or stained for Vα2, Vα8.3, and TCRβ, gated on live CD3+TCRδ+ cells (B). (C) Flow cytometric analysis of LN
cells fromWTmice, stained for Vγ4 and TCRβ, gated on live CD3+ T cells. (D) ImageStream analysis of LN cells fromWTmice, stained for Vγ4, TCRδ, and TCRβ,
and costained with DAPI. (E and F) Flow cytometric analysis of LN cells from WT mice, showing mean fluorescence intensity (MFI) for CD3ε expression, gated
on live CD3+TCRδ+TCRβ− or CD3+TCRδ+TCRβ+ cells (E), or stained for CD4 and CD8α, gated on live CD3+TCRδ+TCRβ+ cells (F). (G) Flow cytometric analysis of
LN cells from WT, TCRα−/−, TCRβ−/−, MHCI−/−, or MHCII−/− mice, stained for Vγ4 and TCRβ, gated on live CD3+TCRδ+ cells. (H) Flow cytometric analysis of
thymocytes isolated from WT mice on E14, E16, and E18, stained for Vγ4 and TCRβ, gated on live CD3+ cells. The gating strategy (A–H) is shown in Fig. S1 A.
(I) Flow cytometric analysis of human PBMCs showing expression of TCRαβ and Vδ2, gated on live CD3+ cells. (J) Percent expression of TCRαβ among Vδ2+
cells in human PBMCs (n = 15 healthy donors), gated on live CD3+ cells. Data are representative of two independent experiments. Flow cytometry plots are
representative of at least three independent experiments (n = 18 samples). BF, brightfield; FMO, fluorescence minus one; SSC, side scatter.
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in infected versus naive mice (Fig. 3 K). Adoptive transfer of
∼10,000 flow-purified Vγ4+TCRβ+ cells from WT mice to IL-
17A−/− mice before infection with S. aureus significantly reduced
bacterial load in the peritoneal cavity and systemic dissemination
to the kidney (Fig. 3 L). These data demonstrate that hybrid
αβ-γδ T cells play a protective role in immunity to S. aureus
infection.
Hybrid αβ-γδ T cells play a critical role in the development of
EAE
The role of γδ T cells in autoimmune diseases is well established
(Sutton et al., 2009). We found that hybrid αβ-γδ T cells were
significantly expanded and secreted IL-17 in the LNs of WT mice
3–10 d after the induction of EAE (Fig. 4, A and B). Hybrid αβ-γδ
T cells also dominated the Vγ4+ compartment in the CNS of
naive mice, and the number of hybrid αβ-γδ T cells in the CNS
was significantly increased 10 d after the induction of EAE (Fig. 4
C). Conventional γδ T cells also infiltrated the brain 7–10 d after
challenge, but CD4+ αβ T cells were numerically dominant by
day 10 (Fig. 4 C). Using a validated in vivo staining technique
with an anti-CD45 antibody administered i.v. immediately be-
fore sacrifice, we demonstrated that hybrid αβ-γδ T cells were
the dominant CNS tissue-resident T cells in naive mice (Fig. 4 D)
and that TCRδ+TCRβ+ cells outnumbered TCRδ+TCRβ– cells on
day 10 of EAE (Fig. 4 E). These CNS-infiltrating hybrid αβ-γδ
T cells displayed an activated, proliferative phenotype (Fig. 4 F)
and secreted IL-17 (Fig. 4 G). Early in EAE (days 3–7), hybrid
αβ-γδ T cells were the dominant IL-17–secreting subset in the
CNS. However, conventional γδ T cells and CD4+ T cells were
also important sources of IL-17 in the CNS, especially as the
disease developed over time, and CD4+ αβ T cells formed the
dominant IL-17–secreting population on day 10 of EAE (Fig. 4 G).
Depletion of Vγ4+ cells in vivo, which removes conventional
Vγ4+ γδ and hybrid Vγ4+ αβ-γδ T cells, significantly impaired
the development of EAE (Fig. 4 H) and limited the infiltration of
cytokine-producing CD4+ T cells into the CNS (Fig. 4 I). To ad-
dress the specific contribution of Vγ4+ hybrid αβ-γδ T cells in
this model, we depleted Vγ4+TCRβ+ cells from the spleens and
LNs of mice immunized with MOG and CFA. Adoptive transfer
of unmanipulated T cells from MOG-immunized mice after ex-
pansion in vitro with MOG, IL-1β, and IL-23 induced EAE. De-
pletion of Vγ4+TCRβ+ cells significantly reduced the production
of IFN-γ, IL-17, and GM-CSF in culture supernatants after in-
cubation with MOG, IL-1β, and IL-23 (Fig. 4 J) and abrogated the
induction of EAE (Fig. 4 K). This attenuated disease course was
associated with significantly reduced frequencies and absolute
numbers of various cytokine-producing T cells in the CNS
(Fig. 4, L and M). To address the contribution of hybrid Vγ4+
αβ-γδ T cells in the priming of encephalitogenic CD4+ T cells, we
depleted hybrid Vγ4+ αβ-γδ T cells from a culture of LN and
spleen cells from MOG-immunized mice before or after culture
with MOG, IL-1β, and IL-23. Depletion of hybrid αβ-γδ T cells
before, but not after, culture significantly impaired the devel-
opment of EAE following adoptive transfer to naive mice
(Fig. 4 N). Cells depleted of hybrid αβ-γδ T cells before culture
with MOG, IL-1β, and IL-23 also expressed significantly lower
amounts of Itga4, which encodes the essential CD4+ T cell traf-
ficking molecule VLA-4 (Fig. 4 O). Moreover, antigen-specific
CD4+ T cells cultured with MOG, IL-1β, and IL-23 in the pres-
ence of hybrid αβ-γδ T cells expressed significantly more IFN-γ
(Fig. 4 P) and Ifng (Fig. 4 Q) and proliferated to a greater extent
(Fig. 4 R) than CD4+ T cells cultured in the absence of hybrid
αβ-γδ T cells. These findings demonstrate that hybrid Vγ4+
αβ-γδ T cells play a nonredundant role in the immunopatho-
genesis of EAE via their ability to migrate to inflammatory sites
and prime encephalitogenic CD4+ T cells.
Hybrid αβ-γδ T cells display a hyperactivated phenotype
Although hybrid αβ-γδ T cells are outnumbered by conventional
γδ T cells, they are rapidly mobilized and play a key pathogenic
role in development of CNS inflammation in the EAE model. To
understand these proinflammatory effects in more detail, we
performed a transcriptomic analysis of hybrid αβ-γδ T cells and
conventional γδ T cells isolated from the LNs of WT mice under
physiological conditions and during EAE.
The data revealed that 1,259 genes were differentially ex-
pressed in hybrid αβ-γδ T cells (Vγ4+TCRβ+) relative to con-
ventional γδ T cells (Vγ4+TCRβ−) under physiological conditions
and that the majority (n = 1,184) of these differentially expressed
genes (DEGs) were up-regulated in hybrid αβ-γδ T cells relative
to conventional γδ T cells (Fig. 5, A and B). Functional enrich-
ment analysis revealed that transcripts associated with T cell
activation, cellular migration, cytokine stimulation, and im-
mune responses to foreign stimuli were enriched in hybrid
αβ-γδ T cells relative to conventional γδ T cells (Fig. 5 C and Fig.
S3 B). Genes associated with the αβ T cell phenotype, including
Cd4, Cd8, Cd6, and Cd28, were expressed at higher levels in hy-
brid αβ-γδ T cells relative to conventional γδ T cells. Hybrid
αβ-γδ T cells also expressed higher levels of genes associated
with cellular trafficking, including Ccr7, Cx3cr1, Ccl22, and Ccl17
(Fig. 5 C). In addition, hybrid αβ-γδ T cells expressed higher
levels of Myd88, Ly96, Tlr2, and Tlr13, suggesting a capacity to
respond to pathogen-associated molecular patterns, as well as
genes associated with IL-1 signaling, including Casp3, Il1b, and
Il18 (Fig. 5 C). A selection of identified DEGs were validated by
flow cytometry (Fig. 5 D).
Separation of hybrid αβ-γδ T cells from conventional γδ
T cells in the principal component analysis plot indicated dif-
ferences in the corresponding gene expression profiles under
physiological conditions and during EAE (Fig. 5 E). Differential
Figure 2. Molecular analysis of TCR expression in flow-purified Vγ4+TCRβ+ cells. Viable CD3+Vγ4+TCRβ+ cells were flow purified from WT mice. (A) Pie
charts display relative population-level frequencies for the Trav, Trbv, Trgv, and Trdv genes depicted in the key (IMGT nomenclature), with the total number of
sequences indicated below. Concatenated data are shown (n = 4 mice). (B) Flow cytometry plots showing index-sorted Vγ4+TCRδ+TCRβ+ cells superimposed
on cloud plots depicting the overall distribution of Vγ4 versus TCRβ (left panel), TCRδ versus TCRβ (middle panel), and Vγ4 versus TCRδ (right panel) in one
mouse with EAE. (C) TCR sequences amplified from the single cells shown in B. Cells and sequences are color matched in B and C.
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expression analysis was used to identify changes in gene ex-
pression levels for each cell type under each condition. DEGs
were more common in hybrid Vγ4+ αβ-γδ T cells (total, n =
2,470; up-regulated, n = 157; down-regulated, n = 2,313) com-
pared with conventional γδ T cells (total, n = 652; up-regulated,
n = 3; down-regulated, n = 649), and most of these genes were
similarly down-regulated in both cell types during EAE (Fig. S3
C). Enrichment analysis further revealed that these down-
regulated genes were associated with T cell activation (cluster
2), cell cycle processes (cluster 3), and mRNA processing and
transport (cluster 4; Fig. S3 C). In contrast, genes associated with
cell migration and chemotaxis, including Vcam1, Ccl2, Ccl8, and
Cxcl13, were preferentially up-regulated in hybrid Vγ4+ αβ-γδ
T cells frommice with EAE (Fig. 5, F and G; and Fig. S3, C and D).
These data suggest that hybrid αβ-γδ T cells are tran-
scriptomically distinct from conventional γδ T cells, with a gene
expression profile indicative of a proinflammatory and migra-
tory phenotype.
Concluding remarks
Conventional αβ and γδ T cells originate from common thy-
mocyte precursors, but the mechanisms that govern subsequent
divergence and lineage fate are incompletely defined. The gen-
eral consensus posits that a strong γδ TCR-mediated signal di-
rects thymocytes to the γδ lineage, whereas a nonproductive
signal permits TCRα rearrangements and commitment to the αβ
lineage (Hayes et al., 2005). However, aberrant expression of
TCR chains has been demonstrated among αβ and γδ T cell
populations (Bowen et al., 2014; Hochstenbach and Brenner,
1989; Ishida et al., 1990). For example, in-frame TCRδ re-
arrangements have been identified in αβ T cells (Livak et al.,
1995), and functional TCRβ rearrangements have been detected
in γδ T cells (Bosco et al., 2008). The latter may even confer a
proliferative advantage and selectively amplify certain subsets
of murine TCRβ+ γδ thymocytes (Wilson and MacDonald, 1998).
Similarly, up to 50% of all Vδ1+ cells in humans are natural killer
T (NKT)–like cells that express TCRα and TCRδ segments with
TCRβ (Pellicci et al., 2014). Of note, given the structure of the
murine TCRα/δ locus, coexpression of αβ and γδ TCRs implies
productive rearrangement of TCRα and TCRδ on different al-
leles. In addition, the murine TCRγ locus has been repeatedly
duplicated on chromosome 13, potentially facilitating multiple
rearrangements (Glusman et al., 2001). It is also notable that
dual-lineage lymphocytes expressing a B cell receptor and an αβ
TCR have recently been identified in humans and linked to the
development of type 1 diabetes (Ahmed et al., 2019).
The collective data presented here identify a novel subset of
hyperinflammatory T cells defined by the coexpression αβ and
γδ TCRs. These intrathymically generated hybrid αβ-γδ T cells
recognized MHC-restricted peptide antigens, like conventional
αβ T cells, and produced IFN-γ, IL-17, and GM-CSF in response to
IL-1β and IL-23, like conventional γδ T cells, defining a niche at
the interface between adaptive and innate immunity. Moreover,
hybrid αβ-γδ T cells expressed chemokine receptors and homing
molecules, facilitating migration to sites of inflammation. Hy-
brid αβ-γδ T cells were expanded at the site of infection with S.
aureus, and adoptive transfer of a very small number of purified
hybrid Vγ4+ αβ-γδ T cells from WT mice conferred protection
against S. aureus infection in IL-17−/−mice. In mice with EAE, IL-
17–producing hybrid αβ-γδ T cells were found in the draining
LNs before the appearance of IL-17–producing αβ T cells. De-
pletion of hybrid Vγ4+ αβ-γδ T cells suppressed the activation of
Th17 cells and abrogated the development of EAE. These findings
suggest that hybrid αβ-γδ T cells are equipped to act as highly
proinflammatory “first responders,” illustrated here in the
context of a bacterial infection and an autoimmune process in
the CNS.
Materials and methods
Mice
C57BL/6 mice, IL-17−/− (C57BL/6 background) mice, OT-I mice
(C57BL/6-Tg(TcraTcrb)1100Mjb/J), which exclusively express
an αβ TCR specific for OVA257–264 restricted by H-2Kb, and OT-II
mice (C57BL/6-Tg(TcraTcrb)425Cbn/J), which exclusively ex-
press an αβ TCR specific for OVA323–339 restricted by I-Ab, were
sourced from the Jackson Laboratory. All mice were bred under
specific pathogen–free conditions and maintained according to
European Union Directives. Experiments were performed with
sex-matched mice (aged 6–8 wk) under license BI00/2412 from
the Irish Health Protection Regulatory Agency with approval
from the Trinity College Dublin Comparative Medicine Ethics
Figure 3. Hybrid αβ-γδ T cells can be activated innately or via αβ or γδ TCRs. (A) Purified Vγ4+ cells or Vγ4-depleted CD3+ cells were stimulated for 3 d
with IL-1β and IL-23 or with medium alone. Data show cytokine production measured by ELISA. (B) Flow cytometric analysis of IL-1R1 and IL-23R expression on
Vγ4+TCRδ+TCRβ+, Vγ4+TCRδ+TCRβ−, or Vγ4–TCRδ−TCRβ+ cells, gated on live CD3+ cells. (C) Relative Ifng and Il17a expression in purified Vγ4+TCRβ+ or
Vγ4+TCRβ− cells stimulated for 3 d with IL-1β, IL-2, and IL-23 in the presence or absence of plate-bound anti-CD3. (D and E) IFN-γ, IL-17, and GM-CSF
production by TCRδ+TCRβ+ or TCRδ+TCRβ− cells (D), or TCRδ+TCRβ+ cells (E), isolated from OT-II mice and stimulated for 3 d with or without OVA-pulsed DCs
in the presence or absence of IL-1β and IL-23 and/or anti-MHCII. Cytokines were measured by ELISA. (F and G) Vγ4+TCRβ+ cells were isolated from MOG-
immunized mice on day 7 and cultured for 3 d with DCs in the presence or absence of MOG and/or IL-1β and IL-23. Relative gene expression was measured by
RT-PCR (F), and cytokines were measured by ELISA (G). PECs were isolated from naive mice or 3 h after i.p. challenge with S. aureus. (H) Cytokine levels in PEC
culture supernatants measured by ELISA. (I) Flow cytometric quantification of TCRδ+ cells, gated on live CD3+ cells. (J) Flow cytometric quantification of
Vγ4+TCRδ+TCRβ+ or Vγ4+TCRδ+TCRβ− cells, gated on live CD3+TCRδ+ cells. (K) Flow cytometric quantification of IFN-γ and IL-17 production by
Vγ4+TCRδ+TCRβ+ cells. (L) Bacterial loads in the peritoneal cavity and kidneys of WT mice 3 d after S. aureus infection or IL-17−/− mice 3 d after adoptive
transfer of Vγ4+TCRβ+ cells from WT mice or mock transfer (PBS). Data are representative of three independent experiments (n = 4–6 in A–K) or combined
from two experiments (n = 8 or 12 in L). Flow cytometry plots in B are representative of six samples. Results are shown as mean ± SEM; *, P < 0.05, **, P < 0.01,
***, P < 0.001, ****, P < 0.0001, #, P < 0.05; ns, not significant; two-way ANOVAwith Tukey’s test for multiple comparisons (A, D, and E), one-way ANOVAwith
Tukey’s test for multiple comparisons (B and L), three-way ANOVA with Tukey’s test for multiple comparisons (C), or unpaired t test (F–K).
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Committee. Embryonic thymus experiments were performed
with C57BL/6 mice at the University of Birmingham, UK. For
timed matings, the day of detection of a vaginal plug was des-
ignated as day 0. Experiments with TCRα−/−, TCRβ−/−, MHCI−/−,
and MHCII−/− mice were performed at the Instituto de Medicina
Molecular, Lisbon, Portugal.
Preparation of human PBMCs
PBMCs were isolated by Ficoll gradient centrifugation from
leukocyte-enriched buffy coats obtained from anonymous
healthy donors via the Irish Blood Transfusion Board, St. James’s
Hospital, Dublin, Ireland. Ethical approval was granted by the
School of Biochemistry and Immunology Research Ethics Com-
mittee, Trinity College Dublin, Ireland.
Antibodies
The following antibodies were used to characterize murine cells
in flow cytometry experiments: anti-CCR2 (clone SA203G11, 0.1
µg/106 cells; BioLegend), anti-CCR6 (clone 140706, 0.1 µg/106
cells; BD Horizon), anti-CCR7 (clone 4B12, 0.1 µg/106 cells;
eBioscience), anti-CD3 (clone 17A2, 0.05 µg/106 cells; Bio-
Legend), anti-CD4 (clone RM4-5, 0.05 µg/106 cells; eBioscience),
anti-CD5 (clone 53–7.3, 0.1 µg/106 cells; BD Biosciences), anti-
CD6 (clone IM348, 0.1 µg/106 cells; eBioscience), anti-CD8α
(clone 53–6.7, 0.05 µg/106 cells; eBioscience), anti-CD25 (clone
PC61, 0.1 µg/106 cells; BioLegend), anti-CD27 (clone LG.7F9, 0.1
µg/106 cells; eBioscience), anti-CD49d (clone R1-2, 0.1 µg/106
cells; eBioscience), anti-CD86 (clone GL1, 0.1 µg/106 cells; Bio-
Legend), anti-CD95 (clone 15A7, 0.1 µg/106 cells; eBioscience),
anti-CD107a (clone 1D4B, 0.1 µg/106 cells; BD Biosciences), anti-
CD115 (clone AFS98, 0.1 µg/106 cells, BioLegend), anti-CD122
(clone TM-b1, 0.1 µg/106 cells; eBioscience), anti-CD284 (clone
MT5510, 0.1 µg/106 cells; BioLegend), anti-CX3CR1 (clone
SA011F11, 0.1 µg/106 cells; BioLegend), anti-GITR (clone DTA1,
0.1 µg/106 cells; eBioscience), anti–GM-CSF (cloneMP1-22E9, 0.1
µg/106 cells; eBioscience), anti-ICOS (clone 7E.17G9, 0.1 µg/106
cells; BioLegend), anti–IFN-γ (clone XMG1.2, 0.1 µg/106 cells;
eBioscience), anti–IL-1R1 (clone 12A6, 0.1 µg/106 cells; BD Bio-
sciences), anti–IL-17 (clone TC11-18H10.1, 0.1 µg/106 cells; Bio-
Legend), anti–IL-23R (clone 078–1208, 0.1 µg/106 cells; BD
Biosciences), anti-TCRβ (clone H57-597, 0.1 µg/106 cells; eBio-
science), anti-TCRδ (clone GL3, 0.1 µg/106 cells; eBioscience),
anti-TLR2 (clone T2.5, 0.1 µg/106 cells; BioLegend), anti-Vα2
(clone B20.1, 0.1 µg/106 cells; BioLegend), anti-Vα8.3 (clone
B21.14, 0.1 µg/106 cells; BioLegend), anti-Vγ1 (clone 2.11, 0.1 µg/
106 cells; BioLegend), and anti-Vγ4 (clone UC3-1OA6, 0.1 µg/106
cells; BioLegend). The following antibodies were used to char-
acterize human cells in flow cytometry experiments: anti-
TCRαβ (clone T10B9.1A-31, 5 µl/test; BD Horizon), anti-CD3
(clone SK7, 1 µl/test; BD Biosciences), and anti-Vδ2 (clone B6,
2.5 µl/test; BioLegend).
Immune cell purification
Purified cell populations were isolated from single-cell suspen-
sions of leukocytes extracted from spleens and LNs. Briefly,
WT cells were enriched by magnetic separation using a Pan
T Cell Isolation Kit (Miltenyi Biotec), labeled with anti-Vγ4
(clone UC3-1OA6, 0.1 µg/106 cells; BioLegend) or anti-TCRδ
(clone GL3, 0.1 µg/106 cells; eBioscience), sorted by flow cy-
tometry, and incubated with anti-TCRβ (clone H57-597, 0.1 µg/
106 cells; eBioscience). Alternatively, WT cells were enriched by
magnetic separation using a γδ T Cell Isolation Kit (Miltenyi
Biotec). In the EAE model, Vγ4+TCRβ+ cells were enriched from
spleens and draining LNs on day 10 after immunization with
MOG and CFA. Distinct cell populations were sorted by flow
cytometry using a FACSAria Fusion (BD Biosciences) or a MoFlo
Legacy (Beckman Coulter).
Cell culture
Cells were cultured in medium with or without various combi-
nations of IL-1β, IL-4, IL-12p70, IL-18, and IL-23 (all 10 ng/ml),
together with IL-2 (1 or 10 ng/ml) or anti–IFN-γ and anti–IL-17
Figure 4. Hybrid Vγ4+ αβ-γδ T cells promote CD4+ T cell homing to the CNS and drive the development of EAE. (A) Absolute numbers of
Vγ4+TCRδ+TCRβ+ cells in the LNs of WT mice on days 0, 3, 7, and 10 of EAE. Right: representative flow cytometry plots. (B) Absolute numbers of IL-17-
producing Vγ4+TCRδ+TCRβ+ cells in the LNs of WT mice on days 0, 3, 7, and 10 of EAE. (C) Absolute numbers of Vγ4+TCRδ+TCRβ–, Vγ4+TCRδ+TCRβ+, or
Vγ4–TCRδ–TCRβ+ cells in the brains of WT mice on days 0, 3, 7, and 10 of EAE. Right: representative flow cytometry plots. (D) Absolute numbers and fre-
quencies of brain-resident TCRδ−TCRβ+, TCRδ+TCRβ+, or TCRδ+TCRβ– cells after gating on CD45 i.v.– cells from naive mice injected with anti-CD45 10 min
before euthanasia. (E) Representative flow cytometry showing expression of TCRβ versus TCRδ on tissue-resident (CD45 i.v.−) T cells from naive mice or mice
with EAE (day 10). (F) Absolute numbers of Ki67+ or CD44+CD69+ Vγ4+TCRδ+TCRβ+ cells in the CNS of WT mice on days 0, 3, 7, and 10 of EAE. (G) Absolute
numbers of IL-17–producing Vγ4+TCRδ+TCRβ+, Vγ4+TCRδ+TCRβ–, or CD4+ Vγ4–TCRδ–TCRβ+ cells in the CNS of WT mice on days 0, 3, 7, and 10 of EAE.
(H and I)WTmice were treated on days –1, 2, 5, 7, 11, and 14with Vγ4-depleting or isotype control antibodies. (H) Clinical scores for EAE. (I) Absolute numbers
of cytokine-producing CD4+ T cells in the spinal cords on day 21 of EAE. (J–M) Total spleen and LN cells or Vγ4+TCRβ+ flow-depleted (Vγ4β-dep) spleen and LN
cells from MOG-immunized mice (day 7) were cultured for 3 d with MOG, IL-1β, and IL-23. (J) IL-17, IFN-γ, and GM-CSF concentrations in culture supernatants
quantified by ELISA. (K) Cultured T cells were transferred to naive mice and clinical scores were recorded for EAE. (L) Absolute numbers and frequencies of
cytokine-producing cells in the brains of recipient mice on day 10 of EAE. (M) Representative flow cytometry plots showing production of IFN-γ versus IL-17,
gated on live CD3+ cells. (N and O) Vγ4+ TCRβ+ T cells were depleted from a culture of LN and spleen cells from MOG-immunized mice before or after culture
with MOG, IL-1β, and IL-23. (N) Cultured T cells were transferred to naive mice and clinical scores were recorded for EAE. (O) Itga4 mRNA was quantified by
RT-PCR in cultured cells before transfer. (P–R) CD4+ T cells were isolated from the spleens and LNs of mice immunized withMOG and CFA (day 7) and cultured
for 3 d with IL-1β, IL-23, and MOG, either in the presence or absence of Vγ4+TCRβ+ cells. (P) IFN-γ in culture supernatants quantified by ELISA. (Q) Ifng
expression in purified CD4+ T cells. (R) Proliferation of CD4+ T cells measured by CFSE dilution. Data are representative of three independent experiments
(n = 6 for A–N) or combined from two experiments (n = 6 for O–R). Results are shown as mean ± SEM; *, P < 0.05, **, P < 0.01, ***, P < 0.001, ****, P < 0.0001;
one-way ANOVA with Tukey’s test for multiple comparisons (A–C, F, and G), two-way ANOVA with Tukey’s test for multiple comparisons (J), repeated
measures (H, K, and N), or unpaired t test (I, L, and O–R).
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(both 1 µg/ml), in the presence or absence of anti-CD3 (clone
145-2C11, 1 µg/ml; BD Biosciences), anti-CD28 (clone 37.51, 2 µg/
ml; BD Biosciences), anti-MHCII (clone IA/IE, 10 µg/ml; eBio-
science), and/or anti-TCRδ (clone UC7-13D5, 10 µg/ml; Bio-
Legend). Culture supernatants were harvested 24–72 h after
T cell activation, and concentrations of IFN-γ, IL-4, IL-17, and
GM-CSF were quantified by ELISA (BD PharMingen or R&D
Systems). For DC co-culture experiments, bone marrow from
C57BL/6 mice was incubated with GM-CSF (20 ng/ml) for 6 d to
generate mature DCs. Mature DCs were washed and incubated
for 5 h at 20,000 cells/well (for culture with magnetically en-
riched γδ T cells) or 2,500 cells/well (for culture with flow-
purified populations) with medium alone (negative control),
OVA257–264 (4 µg/ml; Sigma-Aldrich), OVA323–339 (10 µg/ml;
Sigma-Aldrich), KLH (10 µg/ml; Calbiochem), or MOG35–55 (10
µg/ml; GenScript). Magnetically enriched γδ T cells (105 cells/
well from OT-I mice or 2 × 105 cells/well from OT-II mice), flow-
purified TCRδ+TCRβ+ or TCRδ+TCRβ– cells (20,000 cells/well)
from OT-II mice, or flow-purified Vγ4+TCRβ+ cells (20,000
cells/well) from mice immunized with MOG and CFA were then
co-cultured in the presence or absence of various stimulants
with mature DCs. Culture supernatants were harvested after 2 d
and assayed by ELISA. Cells were harvested simultaneously into
TRIzol Reagent (Thermo Fisher Scientific). For NKG2D ligand-
induced activation, murine YAC-1 cells were cultured in RPMI
1640 medium (Gibco) supplemented with 10% FCS. WT cells
were enriched by magnetic separation using a Pan T Cell Isola-
tion Kit (Miltenyi Biotec) and incubated with or without YAC-1
cells at a 10:1 ratio for 48 h.
Ontogeny experiments
Thymuses from C57BL/6 embryos were isolated on E14, E16, and
E18. Flow cytometric analyses were performed using either a
FACSCantoII or an LSRFortessa (both BD Biosciences).
Flow cytometry
Flow cytometry was performed on LN cells, purified immune
cell populations, and mononuclear cells enriched by Percoll
density centrifugation from the brains and spinal cords of mice
immunized with MOG and CFA. In all experiments, cells were
washed, stained with LIVE/DEAD Fixable Aqua (Life Technolo-
gies), and blocked with anti-CD16/CD32 (1 µg/ml; BD PharMin-
gen). For intracellular staining, mononuclear cells were
incubated for 5 h with brefeldin A (5 µg/ml; Sigma-Aldrich) in
the presence or absence of phorbol myristate acetate (10 ng/ml;
Sigma-Aldrich) and ionomycin (1 µg/ml; Sigma-Aldrich). Intra-
cellular staining for IFN-γ, IL-17, and GM-CSF was conducted
after fixation and permeabilization using a FIX&PERM Cell
Permeabilization Kit (Caltag). Data were acquired using either a
FACSCantoII or an LSRFortessa (both BD Biosciences) and ana-
lyzed with FACSDiva (BD Biosciences) or FlowJo software (Tree
Star). Gates were set on isotype or fluorescence minus one
controls. The gating strategy is depicted in Fig. S1 A.
Imaging flow cytometry
T cells were enriched from LNs by magnetic separation using a
Pan T Cell Isolation Kit (Miltenyi Biotec) and labeled with anti-
TCRβ (clone H57-597, 0.1 µg/106 cells; eBioscience), anti-TCRδ
(clone GL3, 0.1 µg/106 cells; eBioscience), and anti-Vγ4 (clone
UC3-1OA6, 0.1 µg/106 cells; BioLegend). Cells were then fixed
and permeabilized, stained with DAPI (30 mM), and analyzed
using an ImageStreamX Mark II Imaging Flow Cytometer
(Amnis).
Library preparation and RNA sequencing
T cells were enriched from LNs by magnetic separation using a
Pan T Cell Isolation Kit (Miltenyi Biotec), labeled as described
above, and flow purified as Vγ4+TCRδ+TCRβ+ or Vγ4+TCRδ+
TCRβ− populations. Total RNA was isolated using a NucleoSpin
RNA XS Kit according to the manufacturer’s instructions
(Clontech), omitting the carrier RNA and lysate filtration steps,
and eluted in 10 µl of RNase-free water (Qiagen). RNA se-
quencing was performed on total RNA by normalizing the input
mass to cell number according to cell type. For Vγ4+TCRδ+TCRβ−
cells, input was normalized to 30,000 cells where possible (two
samples fell below this input target, reaching totals of 12,687 and
21,772 cells). For Vγ4+TCRδ+TCRβ+ cells, input was normalized to
5,000 cells where possible (three samples fell below this input
target, reaching totals of 2,036, 3,649, and 4,577 cells). cDNA
was amplified using a SMARTer Ultra Low Input RNA Kit for
Figure 5. Hybrid αβ-γδ T cells are transcriptionally distinct from conventional γδ T cells. RNA sequencing analysis of Vγ4+TCRδ+TCRβ+ (Vγ4+TCRβ+) or
Vγ4+TCRδ+TCRβ− (Vγ4+TCRβ−) cells flow sorted from the spleens and LNs of naive WT mice or WT mice on day 3 of EAE. (A) Summary of the data pre-
processing and filtering workflow. (B) NOISeq MD plot of genes passing the low-level filtering cutoff (n = 10,010), highlighting DEGs (n = 1,259) between naive
Vγ4+TCRβ+ and Vγ4+TCRβ– cells. Red dots: genes up-regulated in Vγ4+TCRβ+ cells (n = 1,184). Blue dots: genes down-regulated genes in Vγ4+TCRβ+ cells (n =
75). M represents the log2-fold change in normalized expression values between Vγ4+TCRβ+ and Vγ4+TCRβ− cells. D represents the absolute value of the
difference in expression between Vγ4+TCRβ+ and Vγ4+TCRβ− cells. D values are displayed on a log10 scale. Increasing D values represent increasing differences
in expression levels between Vγ4+TCRβ+ and Vγ4+TCRβ− cells. (C) Heatmaps of selected genes from enriched biological processes derived using gene ontology
enrichment analysis of up-regulated genes between naive Vγ4+TCRβ+ and Vγ4+TCRβ− cells. Expression values were z-transformed for visualization. (D) Flow
cytometric analysis of purified CD3+ cells, comparing naive Vγ4+TCRβ+ and Vγ4+TCRβ− cells, gated on live CD3+TCRδ+ cells. Results are shown as mean ± SEM.
(E) Reduced dimensionality representation of four cell populations via a principal-component analysis plot, where the Vγ4+TCRβ+ and Vγ4+TCRβ− populations
separate along the first principal component (PC1) and the equivalent populations in naive mice or mice with EAE separate along the second principal
component (PC2). (F) Dot plot of the top 10 significantly enriched biological processes inferred from differentially up-regulated genes in Vγ4+TCRβ+ or
Vγ4+TCRβ− cells frommice with EAE versus naive mice (cluster 1 in Fig. S3 C; n = 158 genes). Dot color represents the P-adjusted enrichment value, and dot size
represents the number of genes within each enriched gene ontology. (G) Heatmap of genes associated with chemotaxis/migration among all four populations
derived using the gene ontology enrichment analysis in F. Expression values were z-transformed for visualization. Most of the data are shown for individual
mice (n = 4 or 5 mice per group), except in D, where the data are representative of two experiments (n = 5 mice). *, P < 0.05, **, P < 0.01, ***, P < 0.001, ****,
P < 0.0001; unpaired t test.
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Illumina Sequencing (Clontech) and sequenced at a target depth
of 30 × 106 single-end (1 × 50 bp) reads per sample using a HiSeq
3000 System (Illumina).
Bioinformatic analysis of RNA sequencing data
Reads were mapped against the mouse reference genome
(mm10, Ensembl release 76) using Kallisto (version 0.44; Bray
et al., 2016). Transcript abundances were summarized to gene-
level estimates in R (version 3.4.4) using the tximport Bio-
conductor package (version 1.8; Soneson et al., 2015) and the
makeTxDbFromGFF package with a GTF annotation file from
Ensembl (release 93). Differential expression analysis was per-
formed using the NOISeq R Bioconductor package (version
2.22.1; Tarazona et al., 2015). Lowly expressed genes were re-
moved on the basis of normalized read counts. Genes were kept
if they reached a threshold of ≥100 read counts under any ex-
perimental condition. Data were normalized using the trimmed
mean of log expression values approach in NOISeq. DEGs were
detected using a probability value of 0.99, equivalent to a false
discovery rate of 0.01, and an absolute fold-change cutoff of 2. A
higher threshold of threefold was used for samples from mice
with EAE, which exhibited higher levels of background noise.
Heatmaps and clustering analyses, based on Euclidean distance
with scaling by row, were generated using the ComplexHeatmap
package in R (version 2.1.1; Gu, 2016). Principal-component
analysis was performed using the R functions autoplot (ggfor-
tify v0.4.8) and prcomp (stats v3.5.2) for all genes where the
sum of the normalized read counts from all samples was at least
1,000 (n = 10,010). Gene ontology enrichment analysis was
performed using the clusterProfiler package and the enrichGO
tool in R (version 3.6.0; Yu et al., 2012).
Gene expression analysis
Total RNA was extracted from purified cell populations using the
chloroform/isopropanol method. mRNA expression was evaluated
by real-time PCR after reverse transcription using a High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems). Real-time
PCR was performed for a variety of genes using predesigned
TaqMan Gene Expression Assays (Applied Biosystems). 18s rRNA
was used as an endogenous control. Samples were assayed using a
7500 Fast Real-Time PCR System (Applied Biosystems).
TCR sequencing
For population-level analyses, viable Vγ4+TCRβ+ cells from WT
mice were flow purified directly into RNAlater (Applied Bio-
systems). Unbiased amplification of all expressed Tra, Trb, Trg,
and Trd gene rearrangements was conducted using a template-
switch anchored RT-PCR (Quigley et al., 2011). Amplicons were
subcloned, sampled, sequenced, and analyzed as described pre-
viously (Price et al., 2005). For single-cell analyses, viable
Vγ4+TCRβ+ cells fromWTmice were index-sorted into a 96-well
plate, and expressed Tra, Trb, Trg, and Trd gene rearrangements
were amplified using a previously described protocol with mi-
nor modifications (Dash et al., 2011). Briefly, direct lysis and
reverse transcription were performed using SuperScript Vilo
(Invitrogen). The resultant cDNA was subjected to a first-round
PCR incorporating a cocktail of validated Tra and Trb primers
(Dash et al., 2011), together with newly designed Trg and Trd
primers. The first-round products were subjected to a nested
PCR using internal primer pools on separate 96-well plates for
the α, β, γ, and δ chains, with each product assigned to an
identical location for tracing back to the original cell. The final
products were purified using Exonuclease I/Shrimp Alkaline
Phosphatase. Sequencing was performed with the relevant con-
stant region primers using an ABI Big Dye Sequencer (Applied
Biosystems). Data were analyzed using a custom-built macro-
enabled Microsoft Excel sheet to derive CDR3 nucleotide and
amino acid sequences, and gene use was assigned by matching
sequences against the IMGT database (Lefranc et al., 2009). If
multiple species were observed, potentially reflecting biallelic re-
arrangements, the relevant transcripts were further resolved using
additional PCRs. Briefly, the first-round products from the identi-
fied cell were subjected to another nested PCR using family-specific
forward and reverse primers determined using a trace viewer.
Resolution was further verified by adopting a “leave-one-out”
amplification strategy, where the internal forward primer specific
for the family determined in the previous experiment was with-
held from the cocktail, and the resulting product was sequenced.
Immunofluorescence microscopy
γδ T cells or Vγ4+ cells were flow purified using a FACSAria
Fusion (BD Biosciences). Purified cells were transferred onto
poly-L-lysine–coated chamber slides, incubated for 2 h at 37°C,
fixed in 4% paraformaldehyde for 15 min, and blocked with 20%
FCS for 20 min γδ T cells were immunostained with anti-
TCRβ–Alexa Fluor 647 and phalloidin, and Vγ4+ cells were
immunostained in 5% bovine serum albumin with rabbit anti-
TCRβ, washed, and labeled with a goat anti-mouse secondary
antibody conjugated to Alexa Fluor 594. Slides were mounted
using Mounting Medium with DAPI (DakoCytomation) and
viewed on a point-scanning confocal microscope (FV1000;
Olympus). Confocal images were selected to represent at least 20
captures (n = 3 independent experiments).
S. aureus infection model
Mice were inoculated i.p. with S. aureus (5 × 108 CFU in 100 µl)
and sacrificed after 3 h or 3 d. Peritoneal exudate cells (PECs)
were isolated from infected mice by lavage of the peritoneal
cavity with 3 ml of sterile PBS. Lavage fluid was centrifuged and
assayed for IL-1β, IL-17, and IFN-γ by ELISA. Kidneys were ho-
mogenized in 1 ml of sterile PBS. Total tissue bacterial load was
established by plating serial dilutions of peritoneal lavage fluid
or kidney homogenate on tryptic soy agar plates for 24 h at 37°C.
Results were standardized to CFUs per milliliter.
EAE
Active EAE was induced by injecting mice s.c. with 100 µg of
MOG35–55 peptide (GenScript) emulsified in CFA containing
4 mg/ml (0.4 mg/mouse) of heat-killed Mycobacterium tubercu-
losis (Chondrex). Mice were further injected i.p. with 250 ng of
pertussis toxin (Kaketsuken) on days 0 and 2. In some experi-
ments, mice were treated with anti-Vγ4 or an isotype control
(250 µg/mouse; BioXCell), administered i.p. on days −1, 2, 5, 7, 11,
14, 17, and 20 of EAE. Passive EAE was induced by adoptive
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transfer of MOG-specific cells. C57BL/6 mice were immunized
s.c. with 100 µg of MOG35–55 peptide (GenScript) emulsified
in CFA containing 4 mg/ml (0.4 mg/mouse) of heat-killed M.
tuberculosis (Chondrex). On day 10 after induction, the spleens
and brachial, axillary, and inguinal LNs were removed from
sacrificed mice and prepared as single-cell suspensions. For
Vγ4β-depleted cultures, cells were labeled with anti-TCRβ
(clone H57-597, 0.1 µg/106 cells; eBioscience) and anti-Vγ4
(clone UC3-1OA6, 0.1 µg/106 cells; BioLegend), and Vγ4+TCRβ+
cells were depleted by flow cytometry. Cells were stimulated
with combinations of IL-1β (10 ng/ml), IL-23 (10 ng/ml), and/or
MOG (100 µg/ml) in complete medium at 10 × 106 cells/ml. After
72 h, cells were washed, and cytokine production in the super-
natants was measured by ELISA. A total dose of 5 × 106 viable
cells was injected i.p. into each naive C57BL/6 recipient. Mice
were monitored daily for signs of clinical disease. Clinical signs
of EAE were assessed according to the following scores: no
symptoms, 0; limp tail, 1; ataxic gait, 2; hindlimb weakness, 3;
hindlimb paralysis, 4; tetraparalysis/moribund, 5.
MOG tetramer staining
Draining LNs were removed from mice 7 d after immunization
with MOG and CFA and cultured at 20 × 106 cells/ml in the
presence of IL-2 (5 ng/ml), 2.5% FCS, and MOG or control tet-
ramer (National Institutes of Health Tetramer Facility) for 2.5 h
at 37°C. Naive mice were processed similarly as controls. Cells
were then washed twice and analyzed by flow cytometry as
described above. Gates were set on fluorescence minus one
controls among live CD3+CD4+CD44+ cells.
Data availability
RNA sequencing data for purified Vγ4+TCRδ+TCRβ+ or
Vγ4+TCRδ+TCRβ− from LNs of naive mice or mice with EAE
have been deposited to the Gene Expression Omnibus under
accession no. GSE143500.
Statistical analysis
Statistical analyses were performed using one-way, two-way, and
three-wayANOVAs and unpaired t tests in Prism (GraphPad). Error
bars represent SD or SEM. Levels of significance are denoted as
follows: *, P < 0.05; **, P < 0.01; ***, P < 0.001; and ****, P < 0.0001.
Online supplemental material
Fig. S1 (related to Fig. 1) shows image and flow cytometry data
from T cells that coexpress αβ and γδ TCRs. Fig. S2 (related to
Fig. 4) shows activation data from hybrid αβ-γδ T cells. Fig. S3
(related to Fig. 5) shows RNA sequencing analysis of Vγ4+TCRβ+
and Vγ4+TCRβ− cells before or after activation.
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Figure S1. A novel population of T cells that coexpresses αβ and γδ TCRs. (A) Gating strategy for the analysis of T cell subsets, including hybrid αβ-γδ
T cells, conventional γδ T cells, and CD4+ T cells. (B) Confocal images of purified TCRδ+ cells costained for TCRβ. (C) Trbj expression in purified CD3+ or TCRδ+
cells quantified by RT-PCR. Control: heart cells. *, P < 0.05, ***, P < 0.001. (D) Confocal images of purified CD3+Vγ4+ cells costained for TCRβ. (E) Flow
cytometry plots showing expression of Vγ1 versus Vγ4 on TCRδ+ cells, gated on live TCRβ+ cells. (F) Flow cytometry plots showing expression of TCRδ versus
TCRβ on LN cells, gated on live CD3+Vγ4+TCRδ+ cells. (G) Flow cytometry plots showing CD4 versus CD8α on LN cells fromMHCI−/− or MHCII−/−mice, gated on
live TCRδ+ Vγ4+ TCRβ+ cells. Data are representative of at least three independent experiments. Results are shown as mean ± SEM. P values were calculated
using a one-way ANOVA with Tukey’s test for multiple comparisons (C). FSC, forward scatter.
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Figure S2. Hybrid αβ-γδ T cells can be activated innately or via αβ or γδ TCRs. (A) Coexpression of IL-1R1 and IL-23R on Vγ4+ hybrid αβ-γδ, Vγ4+ γδ
T cells, or αβ T cells. (B) Production of IFN-γ and IL-17 by purified Vγ4+TCRβ+ or Vγ4+TCRβ− cells (3,000 cells/well) stimulated for 3 d with IL-1β and IL-23 in
the presence or absence of plate-bound anti-CD3. (C) Expression of Sox13 and Rorc mRNA in purified Vγ4+TCRβ+ cells stimulated for 2 d with IL-1β and IL-23.
(D) Production of IFN-γ by TCRδ+ cells isolated from OT-II or C57BL/6 mice and cultured for 2 d with DCs pulsed for 5 h with OVA peptide or KLH. (E) Gene
expression in TCRδ+TCRβ+ cells isolated from OT-II mice and cultured for 3 d with DCs in the presence or absence of OVA peptide. (F) Cytokine production by
γδ T cells isolated from OT-II mice stimulated for 3 d with or without OVA peptide in the presence or absence of IL-12p70 + IL-18 (Th1) or IL-4 + anti–IFN-γ +
anti–IL-17 (Th2). (G) Gene expression in Vγ4+TCRβ+ cells isolated fromMOG-immunized mice on day 7 and cultured for 3 d with DCs in the presence or absence
of MOG and/or IL-1β and IL-23. (H) LN cells isolated from 7 d MOG + CFA immunized or naive mice incubated with MOG-tetramer-Pe or control tetramer-Pe,
gated on CD3+CD4+CD44+ cells, examining TCRβ+TCRδ+ and TCRβ+TCRδ− populations. (I) γδ T cells from OT-I mice incubated for 3 d with DCs ± OVA peptide
± IL-12p70 and IFN-γ quantified in supernatants by ELISA. (J) Flow cytometry analysis of NKG2D expression on naive CD3+ T cells gating on TCRβ+ and TCRδ+
populations. (K) CD3+ T cells were incubated with and without YAC-1 cells (10:1) for 48 h. Proliferation was measured through expression of Ki67 by
Vγ4+TCRδ+TCRβ+ versus Vγ4+TCRδ+TCRβ− cells, gated on live CD3+TCRδ+ cells. (L) Gene expression in TCRδ+TCRβ+ cells stimulated for 2 d with anti-TCRδ.
(M) Gene expression in CD3+ cells cultured for 3 d with IL-1β and IL-23 in the presence or absence of anti-TCRδ. Data are representative of at least two
independent experiments. Results are shown as mean ± SEM. P values were calculated using a one-way ANOVA with Tukey’s test for multiple comparisons
(B, D, F, G, I–K, and M) or an unpaired t test (C, E, and L). *, P < 0.05, **, P < 0.01, ***, P < 0.001, and ****, P < 0.0001. ns, not significant.
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Figure S3. Hybrid αβ-γδ T cells are transcriptomically distinct from conventional γδ T cells and express Th17-associated markers. (A) Enriched T cells
isolated from the spleens and LNs of WT mice were stained ex vivo for CCR2, CCR6, CD25, CD27, CD49d, and CD122. Expression was determined on live CD3+
cells coexpressing various combinations of Vγ4, TCRδ, and TCRβ. Data are representative of at least two independent experiments. Results are shown as mean
± SEM. P values were calculated using a one-way ANOVAwith Tukey’s test for multiple comparisons. (B) Dot plot of the top 15 significantly enriched biological
processes inferred from differentially up-regulated genes in Vγ4+TCRβ+ versus Vγ4+TCRβ– cells. Dot color represents the P-adjusted enrichment value, and dot
size represents the number of genes within each enriched ontology. (C) Heatmap of all protein-coding genes that are differentially expressed in Vγ4+TCRβ+ or
Vγ4+TCRβ– cells from mice with EAE versus naive mice (n = 2,686). Genes are clustered using k-means clustering and a cluster size of 4. (D) Heatmap of all
protein-coding genes that are up-regulated in either Vγ4+TCRβ+ or Vγ4+TCRβ− cells from naive mice or mice with EAE (cluster 1 from Fig. S3 C, n = 158 genes).
**, P < 0.01, ***, P < 0.001, and ****, P < 0.0001.
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